Joshua Leaston
Biography:
Meet Joshua Isaac Leaston, a rising star in the medical community and a force for positive change. As a medical student at Stanford School of Medicine and the co-founder of Envision Difference, Joshua is recognized for his exceptional academic achievements, having earned a degree in Neuroscience and Health Science from Northeastern University, and receiving multiple awards and scholarships for his work.
Beyond his academic success, Joshua is dedicated to making a meaningful impact on the world. He founded Envision Difference to tackle the complex issue of homelessness and improve the mental health of those affected. In addition to Envision Difference, Joshua has a proven record of ideation, having founded other organizations, including TrueTone, a company focused on addressing disparities in skin cancer.
In his free time, Joshua exemplifies a well-rounded individual who brings joy and positivity to those around him. He enjoys staying active through working out and playing basketball, demonstrating his commitment to both his mental and physical well-being.
With his academic acumen, creativity, resilience, and focus, Joshua is poised to make a significant impact in the field of medicine. He is a true inspiration, driven by his passion for improving healthcare and making a positive difference in the world.
PAST PUBLICATIONS – Last updated 2-2-23
Meet Joshua Isaac Leaston, a rising star in the medical community and a force for positive change. As a medical student at Stanford School of Medicine and the co-founder of Envision Difference, Joshua is recognized for his exceptional academic achievements, having earned a degree in Neuroscience and Health Science from Northeastern University, and receiving multiple awards and scholarships for his work.
Beyond his academic success, Joshua is dedicated to making a meaningful impact on the world. He founded Envision Difference to tackle the complex issue of homelessness and improve the mental health of those affected. In addition to Envision Difference, Joshua has a proven record of ideation, having founded other organizations, including TrueTone, a company focused on addressing disparities in skin cancer.
In his free time, Joshua exemplifies a well-rounded individual who brings joy and positivity to those around him. He enjoys staying active through working out and playing basketball, demonstrating his commitment to both his mental and physical well-being.
With his academic acumen, creativity, resilience, and focus, Joshua is poised to make a significant impact in the field of medicine. He is a true inspiration, driven by his passion for improving healthcare and making a positive difference in the world.
PAST PUBLICATIONS – Last updated 2-2-23
- Opioid usage in lumbar disc herniation patients with nonsurgical, early, and late surgical treatments
- Psychological Health Outcomes of Unhoused Adolescents: A Rapid Review of Descriptive Epidemiology
- TrueTone: A Digital Solution for Personalized Sunscreen Based on Your Skin Type
- Spinal decompression outcomes in children with psychiatric consultation history
- Predicting neurodevelopmental outcomes in premature infants with deep learning
- Do We Swallow the Waste From Our Brain?
- Quantitative Imaging of Blood-Brain Barrier Permeability Following Repetitive Mild Head Impacts
- Neurovascular imaging with QUTE-CE MRI in APOE4 rats reveals early vascular abnormalities
- Quantitative neuroimaging biomarkers using 3D UTE MRI and ferumoxytol
- Evaluating Comorbidity Index Performance in Patients undergoing Spinal Fusion Procedures Stratified by Race
- Comorbodity index underperformance in patients from low income backgrounds
- Treating mild repetitive mild head injury with a vasopressin V1a receptor antagonist: evidence of suppressed microglia activation and regional cerebral blood volume
- Improvements in outcomes with minimally invasive decompression surgeries
- Adolescents with psychiatric consultation history have an increased risk for adverse outcomes following spinal decompression.
- Evaluating descriptive statistics and predictors of craniectomy outcomes